Why is there a supplement craze if they don’t even work?
Why is there a supplement craze if they don’t even work?
3 hours agoPlanet MoneyNPR
Podcast34 min 54 sec
Listen to Episode
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

The Dietary Supplement Industry is a high-conviction growth sector projected to double to $140 billion over the next seven years, driven by high customer lifetime value and recurring subscription models. Investors should focus on the "picks and shovels" of the industry by targeting White-Label Manufacturers like SMP Nutra, which provide the essential infrastructure for thousands of emerging brands. Prioritize companies that utilize NSF or USP third-party certifications, as these "gold standard" labels mitigate the significant regulatory and quality risks inherent in the DSHEA framework. High-demand ingredients such as Creatine, Lion’s Mane, and Collagen represent the most actionable product trends within the "biohacking" and longevity markets. Despite potential legal challenges from the FTC, established brands like Prevagen demonstrate that marketing-heavy wellness assets often maintain incredible revenue resilience and consumer stickiness.

Detailed Analysis

Dietary Supplement Industry (Sector)

The dietary supplement industry is currently a $70 billion market in the United States and is experiencing rapid growth. Sales have increased by approximately 50% since the COVID-19 pandemic and are projected to double over the next seven years.

  • Market Drivers:
    • Increased consumer focus on "biohacking," longevity, and gut health.
    • High influence from social media platforms like TikTok and Instagram.
    • General distrust in traditional pharmaceutical industries and government institutions.
    • High Customer Lifetime Value (CLV): Unlike one-time purchases (e.g., yoga mats), supplements are recurring monthly subscriptions.
  • Regulatory Environment:
    • Supplements are regulated as food, not drugs, under the Dietary Supplement Health and Education Act of 1994 (DSHEA).
    • Manufacturers do not have to prove a product is effective or safe before selling it.
    • The FDA can only intervene after a product is on the market and proven to be an "imminent hazard."
  • Manufacturing Dynamics:
    • Low barrier to entry: Entrepreneurs can use "stock formulas" from manufacturers like SMP Nutra for as little as $5,500 to start a brand.
    • White-labeling is common: The same gummy or pill is often sold by multiple different brands under different labels.

Takeaways

  • Sector Growth: The industry is a high-growth area for investors, driven by recurring revenue models and a massive shift toward "wellness" spending.
  • Regulatory Risk: While the current environment is extremely lax, any future shift in FDA power (though historically resisted by consumers) remains a long-term structural risk.
  • Due Diligence: Investors should be wary of "proprietary blends." The lack of pre-market testing means brand reputation and third-party certifications are the only real safeguards for quality.

White-Label Supplement Manufacturers (e.g., SMP Nutra)

Companies like SMP Nutra act as the "backbone" of the supplement craze, providing the infrastructure for influencers and entrepreneurs to launch brands quickly.

  • Business Model: They offer capsules, tablets, powders, and gummies. They provide both fully customized formulas and "stock" options.
  • Cost Structure: A custom order might require a minimum of ~8,300 bottles at a cost of $4.50 to $7.00 per bottle (roughly a $33,000–$58,000 initial investment).
  • Compliance Guidance: Manufacturers often guide brands on how to use "structure/function" claims to stay legal (e.g., saying "supports metabolism" instead of "burns fat").

Takeaways

  • Infrastructure Play: Investing in the "picks and shovels" (the manufacturers) of the supplement industry may be more stable than betting on individual influencer brands, which have high turnover.
  • Scalability: These factories produce millions of units annually, benefiting from the proliferation of thousands of small-to-medium-sized supplement brands.

Specific Supplement Ingredients & Trends

The transcript highlights several high-demand ingredients that are currently trending in the "wellness" and "biohacking" spaces.

  • Creatine & Lion’s Mane: Frequently marketed for "focus" and brain function.
  • Collagen: Popular for hair growth and skin thickness.
  • Ashwagandha & Theanine: Common ingredients for stress and mental clarity.
  • Green Tea Extract (EGCG): Marketed for energy and metabolism support.
  • Turmeric & Elderberry: High-volume herbal supplements, though frequently flagged for quality inconsistencies.

Takeaways

  • Ingredient Risk: High-concentration extracts (like green tea EGCG) have been linked to liver toxicity. Investors in specific ingredient-focused companies should monitor potential health safety scandals that could trigger FTC lawsuits.
  • Quality Verification: Look for brands that utilize NSF or USP third-party testing. These certifications are "gold standards" that indicate the bottle actually contains what the label claims.

Prevagen (Apoaequorin)

A specific case study of Prevagen, a memory supplement originally derived from a synthetic protein found in glowing jellyfish.

  • The "GRAS" Loophole: The company bypassed FDA safety objections by first introducing the ingredient into a food product (a shake), declaring it "Generally Recognized as Safe" (GRAS), and then moving it into supplement form.
  • Financial Performance: Despite legal challenges, the company saw $165 million in sales between 2007 and 2015.
  • Legal Standing: The FTC sued for false advertising in 2017. While the company lost and had to change its "clinically proven" claims, the product remains a top seller on Amazon.

Takeaways

  • Resilience of Brands: Even with federal lawsuits and scientific skepticism, established supplement brands show incredible "stickiness" with consumers.
  • Marketing over Science: In this sector, marketing efficacy often outweighs clinical efficacy in driving revenue.
Ask about this postAnswers are grounded in this post's content.
Episode Description
One reason the $70 billion supplement industry is set to double in the next seven years? Lax regulation. On today's show, we tell the story of a century-long battle between the U.S. government and … you, the people, blinded by your love of a magic pill. We’re talking about protein powders, pre-workouts, creatine, stuff for gut health, joint health, vitamin C, turmeric supplements. All that. You might not wanna hear this. Sources mentioned in the episode: Marion Nestle, Food Politics Catherine Price, Vitamania Support: Planet Money+ Read:  Our book: Planet Money: A Guide to the Economic Forces That Shape Your Life  Our weekly longform Planet Money newsletter Our weekly Indicator round-up newsletter Follow:  Instagram TikTok YouTube Facebook This episode was hosted by Sarah Gonzalez and Jane Black. It was produced by Sam Yellowhorse Kesler, edited by Marianne McCune, and fact checked by Sierra Juarez with help with Vito Emanuel. It was engineered by Robert Rodriguez with help from Jimmy Keeley. Alex Goldmark is Planet Money’s executive producer.  See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy
About Planet Money
Planet Money

Planet Money

By NPR

Wanna see a trick? Give us any topic and we can tie it back to the economy. At <em>Planet Money</em>, we explore the forces that shape our lives and bring you along for the ride. Don't just understand the economy – understand the world.<br><br><em>Wanna go deeper? <em>Subscribe to </em><em>Planet Money+ and get sponsor-free episodes of Planet Money, The Indicator, and Planet Money Summer School. Plus access to bonus content. It's a new way to support the show you love. Learn more at plus.npr.org/planetmoney</em><br></em>